Rosin derivative idoamp inhibits prostate cancer growth via activating ripk1/ripk3/mlkl signaling pathway

HIGHLIGHTS

  • who: Rosin Derivative IAMP Inhibits and colleagues from the Department of Urology, The Affiliated Hospital of Jiaxing University, Jiaxing, China have published the research: Rosin Derivative IDOAMP Inhibits Prostate Cancer Growth via Activating RIPK1/RIPK3/MLKL Signaling Pathway, in the Journal: Oxidative Medicine and Cellular Longevity of 25/07/2022
  • what: In this study the effects and possible mechanism of the IDOAMP on were investigated. It is termed as IDOAMP because of its chemical structure, and the authors investigate that this IDOAMP has the potential to suppress PCa. The authors found that a newly developed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?